Regenerative Medical Technology (RMTG) Operating Leases (2022 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Operating Leases of $591731.0 for Q1 2026, up 167.72% year-over-year from $221030.0 in Q1 2025, and up 44.64% quarter-over-quarter from $409110.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Operating Leases (2022 - 2026) Analysis & Trends
Regenerative Medical Technology's Operating Leases history runs 5 years deep, the most recent figure standing at $591731.0 for Q1 2026.
- In Q1 2026, Operating Leases rose 167.72% year-over-year to $591731.0; the TTM figure through Mar 2026 stood at $591731.0 (up 167.72% YoY), while the FY2025 annual figure was $409110.0, up 93.24% from the prior year.
- Operating Leases for Q1 2026 stood at $591731.0, up from $409110.0 in the prior quarter.
- The five-year high for Operating Leases was $591731.0 in Q1 2026, with the low at $1395.0 in Q4 2022.
- The 5-year median for Operating Leases is $90440.0 (2022), against an average of $163546.1.
- The sharpest annual moves came in 2024 and 2025: Operating Leases surged 7700.88% in 2024, then soared 76.82% in 2025.
- Regenerative Medical Technology's Operating Leases stood at $1395.0 in 2022, then surged by 94.55% to $2714.0 in 2023, then soared by 7700.88% to $211716.0 in 2024, then jumped by 93.24% to $409110.0 in 2025, then jumped by 44.64% to $591731.0 in 2026.
- Business Quant data shows RMTG's Operating Leases at $591731.0 in Q1 2026, $409110.0 in Q4 2025, and $357272.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Regenerative Medical Technology | 961,772.49 | -99,675.51 | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 591,731.00 |
| Dec 31, 2025 | 409,110.00 |
| Sep 30, 2025 | 357,272.00 |
| Jun 30, 2025 | 209,285.00 |
| Mar 31, 2025 | 221,030.00 |
| Dec 31, 2024 | 211,716.00 |
| Sep 30, 2024 | 14,893.00 |
| Jun 30, 2024 | 32,066.00 |
| Mar 31, 2024 | 125,004.00 |
| Dec 31, 2023 | 2,714.00 |
| Dec 31, 2022 | 1,395.00 |
| Sep 30, 2022 | 41,409.00 |
| Jun 30, 2022 | 16,144.00 |
| Mar 31, 2022 | 55,876.00 |